title: Omega-3 fatty acids and depression: from cellular mechanisms to clinical care.
authors.affiliation: Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Marlene P
authors.initials: MP
authors.lastname: Freeman
authors.forename: Mark H
authors.initials: MH
authors.lastname: Rapaport
mesh_terms: D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D055495:Neurogenesis / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013570:Synaptic Membranes / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D015525:Fatty Acids, Omega-3; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid